Defining the role of toxin-antitoxin systems in persistence of Burkholderia pseudomallei
定义毒素-抗毒素系统在类鼻疽伯克霍尔德杆菌持久性中的作用
基本信息
- 批准号:10194359
- 负责人:
- 金额:$ 19.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-16 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:Antibiotic ResistanceAntibioticsAreaBacteriaBacterial InfectionsBig DataBioinformaticsBurkholderia pseudomalleiCategoriesCell SurvivalCenters for Disease Control and Prevention (U.S.)Cessation of lifeChronicChronic DiseaseComplexDataData AnalysesDevelopmentDiseaseDisease OutcomeDrug DesignEndemic DiseasesEvaluationExhibitsExposure toFrequenciesGenetic TranscriptionGenomeGenomicsGoalsHealthHumanIn VitroInfectionLeftLungMapsMelioidosisMolecularMorbidity - disease rateMusMutationMycobacterium tuberculosisNotificationOrganismOutcomePatientsPhenotypePlayPreventionProcessProteomePublic HealthPuerto RicoRelapseReportingResearchResistanceRoleSchemeSoilStressSystemSystems DevelopmentTestingTexasTherapeuticToxinTreatment FailureTuberculosisUnited States Virgin IslandsUp-Regulationacute infectionantibiotic toleranceantitoxinattenuationbioinformatics toolbiothreatcell typechronic infectioncombateffective therapyemerging pathogenena proteinimprovedin vivoinnovationlatent infectionmacrophagemetabolomemortalitymouse modelmultidrug tolerancemutantnew therapeutic targetnoveloverexpressionpathogenpreventresponsesalmonella toxinstressortranscriptome
项目摘要
Project Summary/Abstract
There is an urgent need to combat infections caused by Burkholderia pseudomallei, the bacterial agent
responsible for the disease melioidosis. Melioidosis is a health threat in tropical endemic regions of the world
and is now recognized as an emergent disease in areas considered non-endemic. In addition to causing acute
infections that are considered lethal if left untreated, the bacteria can persist in the host and produce very
difficult to treat latent infections. Therefore, our long-term goal is to develop effective treatments against
melioidosis and prevent latent or chronic disease outcomes. In this project, we will evaluate the function of a
subset of toxin-antitoxin systems that have been identified as one of the bacterial switches that sense stress
and activate a persistence phenotype. We will determine their association with bacterial persistence both in
vitro and in vivo. Our central hypothesis is that selective toxins are upregulated in vivo in response to specific
conditions, and loss of their function results in reduced host-associated persistence. It is important to point out
that current antibiotics used against B. pseudomallei generate persister frequencies of up to 50%. Because
current treatments last months due to the propensity of B. pseudomallei to generate latent infections, the study
of toxin-antitoxin systems can help identify new drug targets and therefore improve antibiotic efficacy. Our
proposed experimental approach will focus on two specific aims: first, we will evaluate the role of selected
toxins in survival and induction of a persistent stage during B. pseudomallei infection of macrophages because
this cell type likely facilitates latent infections; secondly, we will evaluate the contribution of the toxins in B.
pseudomallei's ability to persist during host-associated in vivo conditions. Our proposal is significant because it
is expected to elucidate the role of the specific toxins that have a strong association with the persistence
phenotype, and this might result in the development of alternative therapeutic approaches to prevent latent
infections caused by B. pseudomallei, a CDC Category B Tier 1 Select Biothreat Agent and an understudied
emerging pathogen.
项目总结/摘要
迫切需要对抗由细菌病原体类鼻疽伯克霍尔德氏菌引起的感染
导致了类鼻疽病类鼻疽是世界上热带流行地区的一种健康威胁
并且现在被认为是在非流行性地区的紧急疾病。除了引起急性
感染被认为是致命的,如果不治疗,细菌可以坚持在主机和产生非常
很难治疗潜伏感染。因此,我们的长期目标是开发有效的治疗方法,
类鼻疽和预防潜伏或慢性疾病的结果。在这个项目中,我们将评估一个
毒素-抗毒素系统的子集,已被鉴定为感知应激的细菌开关之一
并激活一种持久性表型。我们将确定它们与细菌持久性的关系,
体外和体内。我们的中心假设是,选择性毒素在体内上调,以响应特定的
条件下,其功能的丧失导致宿主相关持久性降低。必须指出
目前针对B的抗生素。假鼻疽产生的持续感染率高达50%。因为
由于B的倾向,目前的治疗持续数月。假鼻疽产生潜伏感染,
毒素-抗毒素系统的研究可以帮助确定新的药物靶点,从而提高抗生素的疗效。我们
拟议的实验方法将集中在两个具体目标:首先,我们将评估选定的作用,
毒素在存活和诱导过程中的一个持续阶段B。巨噬细胞的假鼻疽感染,
这种细胞类型可能促进潜伏感染;其次,我们将评估B中毒素的作用。
假鼻疽在宿主相关的体内条件下持续存在的能力。我们的建议意义重大,因为它
有望阐明与持久性有很强关联的特定毒素的作用
表型,这可能会导致替代治疗方法的发展,以防止潜在的
由B引起的感染。类鼻疽,CDC类别B 1级选择生物威胁剂和一种待研究的
新兴病原体
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Optimization of Multivalent Gold Nanoparticle Vaccines Eliciting Humoral and Cellular Immunity in an In Vivo Model of Enterohemorrhagic Escherichia coli O157:H7 Colonization.
- DOI:10.1128/msphere.00934-21
- 发表时间:2022-02-23
- 期刊:
- 影响因子:4.8
- 作者:Sanchez-Villamil JI;Tapia D;Torres AG
- 通讯作者:Torres AG
Multinucleated Giant Cell Formation as a Portal to Chronic Bacterial Infections.
- DOI:10.3390/microorganisms8111637
- 发表时间:2020-10-23
- 期刊:
- 影响因子:4.5
- 作者:Stockton JL;Torres AG
- 通讯作者:Torres AG
Predicting toxins found in toxin-antitoxin systems with a role in host-induced Burkholderia pseudomallei persistence.
- DOI:10.1038/s41598-020-73887-3
- 发表时间:2020-10-09
- 期刊:
- 影响因子:4.6
- 作者:Ross BN;Thiriot JD;Wilson SM;Torres AG
- 通讯作者:Torres AG
Evaluating the Contribution of the Predicted Toxin-Antitoxin System HigBA to Persistence, Biofilm Formation, and Virulence in Burkholderia pseudomallei.
评估预测的毒素-抗毒素系统 HigBA 对类鼻疽伯克霍尔德杆菌的持久性、生物膜形成和毒力的贡献。
- DOI:10.1128/iai.00035-22
- 发表时间:2022
- 期刊:
- 影响因子:3.1
- 作者:Chapartegui-González,Itziar;Khakhum,Nittaya;Stockton,JacobL;Torres,AlfredoG
- 通讯作者:Torres,AlfredoG
Recent Progress in Shigella and Burkholderia pseudomallei Vaccines.
- DOI:10.3390/pathogens10111353
- 发表时间:2021-10-20
- 期刊:
- 影响因子:0
- 作者:Chapartegui-González I;Bowser S;Torres AG;Khakhum N
- 通讯作者:Khakhum N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alfredo G Torres其他文献
Alfredo G Torres的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alfredo G Torres', 18)}}的其他基金
Developing effective nanovaccines against pathogenic Escherichia coli
开发针对致病性大肠杆菌的有效纳米疫苗
- 批准号:
10413247 - 财政年份:2021
- 资助金额:
$ 19.75万 - 项目类别:
Developing effective nanovaccines against pathogenic Escherichia coli
开发针对致病性大肠杆菌的有效纳米疫苗
- 批准号:
10300897 - 财政年份:2021
- 资助金额:
$ 19.75万 - 项目类别:
Glycoconjugate Nanoparticle Vaccines Against Burkholderia Infections
针对伯克霍尔德氏菌感染的糖复合物纳米颗粒疫苗
- 批准号:
9186787 - 财政年份:2016
- 资助金额:
$ 19.75万 - 项目类别:
Glycoconjugate Nanoparticle Vaccines Against Burkholderia Infections
针对伯克霍尔德氏菌感染的糖复合物纳米颗粒疫苗
- 批准号:
9282736 - 财政年份:2016
- 资助金额:
$ 19.75万 - 项目类别:
Vaccine Development for Burkholderia amllei and B. pseudomallei
鼻疽伯克霍尔德杆菌和类鼻疽伯克霍尔德杆菌的疫苗开发
- 批准号:
8377054 - 财政年份:2012
- 资助金额:
$ 19.75万 - 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
- 批准号:
7846683 - 财政年份:2009
- 资助金额:
$ 19.75万 - 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
- 批准号:
7795038 - 财政年份:2009
- 资助金额:
$ 19.75万 - 项目类别:
Long Polar Fimbriae of Attaching and Effacing Escherichia coli
附着和消除大肠杆菌的长极菌毛
- 批准号:
7662935 - 财政年份:2009
- 资助金额:
$ 19.75万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Studentship














{{item.name}}会员




